Display Settings:

Format
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.

The Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients with Celiac Disease.

Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, Marcantonio A, Adelman DC, Mäki M.

Gastroenterology. 2014 Feb 25. pii: S0016-5085(14)00242-X. doi: 10.1053/j.gastro.2014.02.031. [Epub ahead of print]

PMID:
24583059
[PubMed - as supplied by publisher]
2.

Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials.

Siegel M, Garber ME, Spencer AG, Botwick W, Kumar P, Williams RN, Kozuka K, Shreeniwas R, Pratha V, Adelman DC.

Dig Dis Sci. 2012 Feb;57(2):440-50. doi: 10.1007/s10620-011-1906-5. Epub 2011 Sep 23.

PMID:
21948339
[PubMed - indexed for MEDLINE]

Supplemental Content

Loading ...
Write to the Help Desk